<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00115011</url>
  </required_header>
  <id_info>
    <org_study_id>2002-P-000888</org_study_id>
    <secondary_id>LXP-MD-36</secondary_id>
    <secondary_id>1200-211220</secondary_id>
    <nct_id>NCT00115011</nct_id>
  </id_info>
  <brief_title>Escitalopram for the Treatment of Self-Injurious Skin Picking</brief_title>
  <official_title>Escitalopram for the Treatment of Self-Injurious Skin Picking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Forest Laboratories</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of escitalopram in treating&#xD;
      self-injurious skin picking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: Self-injurious skin picking is a problem documented to occur in 2 % of dermatology&#xD;
      patients (Gupta, Gupta and Haberman, 1986) , and approximately 4% of the general population&#xD;
      (Keuthen et al., 2000). It is widely under recognized, with medical sequelae that can include&#xD;
      scarring, infections, lesions, and potentially life-threatening outcomes (O'Sullivan et al.,&#xD;
      1999). In a prior study, fluoxetine was shown to be superior to placebo in treating&#xD;
      self-injurious skin picking in a modest-sized double blind trial (Simeon et al., 1997).&#xD;
      Similarly, open-label trials of other SSRIs, including sertraline (Kalivas, Kalivas and&#xD;
      Gilman, 1996) and fluvoxamine (Arnold et al., 1999) resulted in reductions in skin-picking&#xD;
      behavior. Escitalopram is a new SSRI that may have superior efficacy for the treatment of&#xD;
      major depression and fewer side effects than other SSRIs. This study aims to assess the&#xD;
      efficacy of escitalopram in patients who suffer from self-injurious skin-picking.&#xD;
&#xD;
      Comparisons: Subjects' initial scores on the CGI, HAM-D, SPTS, SPS, SPIS, BDI, BAI, QLESQ, &amp;&#xD;
      BDDQ will be compared to subjects' final scores.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2002</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MGH Skin Picking Scale</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Picking Impact Scale</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Picking Treatment Scale</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Global Impressions scale</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Enjoyment and Satisfaction Scale</measure>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Impulse Control Disorders</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escitalopram</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Repetitive skin picking resulting in noticeable tissue damage and associated emotional&#xD;
             distress and/or functional impairment.&#xD;
&#xD;
          -  Age 18-65 years old.&#xD;
&#xD;
          -  Duration of skin picking symptoms ≥ 6 months.&#xD;
&#xD;
          -  MGH Skin Picking Scale score ≥ 10.&#xD;
&#xD;
          -  Written informed consent.&#xD;
&#xD;
          -  Females of childbearing potential must have a negative serum or urinary beta-HCG test&#xD;
             and be willing to use acceptable methods of birth control during study tenure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women or females of childbearing potential who do not consent to use of a&#xD;
             medically acceptable method of contraception.&#xD;
&#xD;
          -  Women who are breastfeeding.&#xD;
&#xD;
          -  Subjects who pose a serious suicidal or homicidal risk in the judgment of study&#xD;
             investigators.&#xD;
&#xD;
          -  Serious or unstable medical illness including cardiovascular, hepatic, renal,&#xD;
             respiratory, endocrine, neurologic, or hematologic disease.&#xD;
&#xD;
          -  Subjects with a dermatologic disorder that causes pruritis.&#xD;
&#xD;
          -  Patients on anticoagulant therapy.&#xD;
&#xD;
          -  History of seizure disorder.&#xD;
&#xD;
          -  Comorbid bipolar disorder, psychosis, organic mental disorder, borderline personality&#xD;
             disorder or developmental disorder. Subjects with obsessive compulsive disorder (with&#xD;
             primary symptoms other than compulsive skin picking).&#xD;
&#xD;
          -  History of substance dependence. If there is a history of substance abuse, subjects&#xD;
             should be in remission for ≥ 6 months.&#xD;
&#xD;
          -  Current treatment with cognitive behavioral therapy for skin picking.&#xD;
&#xD;
          -  Current use of another SSRI medication.&#xD;
&#xD;
          -  Other medications for medical disorders that might interfere with escitalopram.&#xD;
&#xD;
          -  Current major depression or prescribed an antidepressant for major depression within&#xD;
             the past 12 months.&#xD;
&#xD;
          -  More than 1 adequate trial (at least 10 weeks at maximally tolerated dose) with&#xD;
             another prior SSRI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy J Keuthen, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gupta MA, Gupta AK, Haberman HF. Neurotic excoriations: a review and some new perspectives. Compr Psychiatry. 1986 Jul-Aug;27(4):381-6.</citation>
    <PMID>3731771</PMID>
  </reference>
  <reference>
    <citation>Keuthen NJ, Deckersbach T, Wilhelm S, Hale E, Fraim C, Baer L, O'Sullivan RL, Jenike MA. Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics. 2000 May-Jun;41(3):210-5.</citation>
    <PMID>10849452</PMID>
  </reference>
  <reference>
    <citation>O'Sullivan RL, Phillips KA, Keuthen NJ, Wilhelm S. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics. 1999 Jan-Feb;40(1):79-81.</citation>
    <PMID>9989126</PMID>
  </reference>
  <reference>
    <citation>Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997 Aug;58(8):341-7.</citation>
    <PMID>9515971</PMID>
  </reference>
  <reference>
    <citation>Kalivas J, Kalivas L, Gilman D, Hayden CT. Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol. 1996 May;132(5):589-90.</citation>
    <PMID>8624163</PMID>
  </reference>
  <reference>
    <citation>Arnold LM, Mutasim DF, Dwight MM, Lamerson CL, Morris EM, McElroy SL. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999 Feb;19(1):15-8.</citation>
    <PMID>9934938</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <study_first_submitted>June 20, 2005</study_first_submitted>
  <study_first_submitted_qc>June 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2005</study_first_posted>
  <last_update_submitted>May 19, 2008</last_update_submitted>
  <last_update_submitted_qc>May 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>Darin Dougherty, MD</name_title>
    <organization>Massachusetts General Hospital</organization>
  </responsible_party>
  <keyword>Skin Picking</keyword>
  <keyword>Escitalopram</keyword>
  <keyword>Lexapro</keyword>
  <keyword>Body Focused Repetitive Behaviors</keyword>
  <keyword>Obsessive Compulsive Spectrum Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disruptive, Impulse Control, and Conduct Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

